Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02927223 · ClinicalTrials.gov registry record · NA
Atropine in Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)
A NA study, sponsored by Vanderbilt University.
- Completed
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT02927223 is a NA study that has completed, run by Vanderbilt University. The registered enrollment target is 6 participants.
The verdict
NCT02927223, a NA study, has completed, sponsored by Vanderbilt University.
- COMPLETED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
To test the hypothesis that increasing the sinus node rate with atropine treatment prior to exercise will reduce exercise-triggered ventricular ectopy compared to baseline in patients with CPVT.
Interventions
- DRUG Atropine
- PROCEDURE Exercise treadmill test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2016-10 |
| Est. Completion | 2019-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02927223
The ClinicalTrials.gov registry entry for NCT02927223 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Atropine is the first listed.
NCT02927223 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02927223 about?
NCT02927223 is a clinical study titled "Atropine in Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)". To test the hypothesis that increasing the sinus node rate with atropine treatment prior to exercise will reduce exercise-triggered ventricular ectopy compared to baseline in patients with CPVT.
What is the current status of trial NCT02927223?
This trial is currently completed. It is a NA study. The enrollment target is 6 participants. The study started on 2016-10. Estimated completion is 2019-02.
What interventions are being tested in trial NCT02927223?
The interventions under investigation include: Atropine (DRUG), Exercise treadmill test (PROCEDURE).
Who is sponsoring clinical trial NCT02927223?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.